Rapid Treatment of Anhedonia With Pramipexole as Adjunct to Buprenorphine in Opioid Use Disorder

Prim Care Companion CNS Disord. 2023 Oct 26;25(5):22cr03535. doi: 10.4088/PCC.22cr03535.

Authors

Clare E Laubenthal^{1

2}, Rodrigo Escalona^{1

3}, Jaclyn E Welch¹

Affiliations

¹ New Mexico VA Health Care System, Albuquerque, New Mexico.
² Corresponding Author: Clare E. Laubenthal, PA-C, Department of Psychiatry, Mayo Clinic Health System, 1025 Marsh St, Mankato, MN 56001-4752 (clare.laub@gmail.com).
³ University of New Mexico School of Medicine, Department of Psychiatry and Behavioral Sciences, Albuquerque, New Mexico (Escalona).

PMID: 37923547
DOI: 10.4088/PCC.22cr03535

No abstract available

MeSH terms

Anhedonia
Buprenorphine* / therapeutic use
Humans
Narcotic Antagonists / therapeutic use
Opioid-Related Disorders* / drug therapy
Pramipexole

Substances

Buprenorphine
Pramipexole
Narcotic Antagonists